Asia-Pacific markets trade mostly higher after Trump-Xi truce

Asia-Pacific markets trade mostly higher after Trump-Xi truce


An electronic board shows Shanghai and Shenzhen stock indices as people walk on a pedestrian bridge at the Lujiazui financial district in Shanghai, China April 3, 2025. 

Go Nakamura | Reuters

Asia-Pacific markets opened mostly higher Friday as investors weighed the state of the economy after the truce between U.S. President Donald Trump and his Chinese counterpart Xi Jinping.

Both parties reached a trade truce during a high-stakes meeting in South Korea on Thursday, de-escalating a dispute over rare earth elements that had threatened to push the world’s two largest economies into a full-blown trade war.

“Both sides appear to be maintaining leverage for future negotiations by keeping these measures as bargaining chips,” said JPMorgan Asset Management’s global market strategist, Chaoping Zhu.

Japan’s Nikkei 225 rose 0.64%, while the Topix added 0.46%. South Korea’s Kospi slid 0.19% after hitting a fresh record high on Thursday. The small-cap Kosdaq rose 0.47%.

Australia’s S&P/ASX 200 started the day 0.45% higher.

Hong Kong’s Hang Seng index was poised to fall. HSI futures were at 26,256, lower than the HSI’s last close of 26,282.69.

China is set to release its purchasing managers’ index for October later today, which provides a snapshot of factory and services activity that investors widely track.

Overnight in the U.S., all three major averages closed lower as investors digested a batch of Big Tech earnings. The S&P 500 dipped 0.99% to finish the day at 6,822.34, while the Nasdaq Composite dropped 1.57% to close at 23,581.14. The Dow Jones Industrial Average traded down 109.88 points, or 0.23%, to 47,522.12.

— CNBC’s Sean Conlon and Sarah Min contributed to this report.



Source

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval
World

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval

Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be […]

Read More
Singapore consumer inflation remains steady at 1.2% in November, missing estimates
World

Singapore consumer inflation remains steady at 1.2% in November, missing estimates

An aerial view of Singapore’s Marina Bay Street Circuit on Sept. 17, 2024. Roslan Rahman | Afp | Getty Images Singapore’s inflation in November remained steady at 1.2%, missing estimates, as a higher increase in prices of services was offset by a steeper decline in electricity costs. The reading was lower than Reuters-polled analysts’ median […]

Read More
China’s second attempt at completing a reusable rocket test fails
World

China’s second attempt at completing a reusable rocket test fails

WENCHANG, CHINA – DECEMBER 20: A Long March-5 rocket carrying a new communication technology test satellite blasts off from the Wenchang Space Launch Site on December 20, 2025 in Wenchang, Hainan Province of China. China News Service | China News Service | Getty Images The first stage of China’s reusable Long March 12A “was not […]

Read More